[
    {
        "utterance": "Emily Balskus: whatever way is convenient until we come back together. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lawrence David: Sounds good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Okay. Yeah, so let's just take a minute to to think. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Harris Wang: [Silence] ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of verbal contribution",
                    "definition": "The speaker's turn consists solely of silence, indicating an absence of spoken input or engagement in the ongoing discussion.",
                    "justification": "The utterance explicitly records '[Silence]', demonstrating that the speaker did not contribute verbally during their turn, which can hinder collaborative progress. The exact quote is '[Silence]'."
                }
            ]
        }
    },
    {
        "utterance": "Abhishek Shrivastava: We have a bot in our zoom room. Bot five. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Off-topic comment",
                    "definition": "A statement that deviates from the main subject of discussion, potentially diverting attention or hindering progress towards the meeting's objectives.",
                    "justification": "The speaker makes an observation about the meeting's technical setup (\"We have a bot in our zoom room. Bot five. .\") which is unrelated to the scientific problem domain or the goal of forming teams, thus diverting from the meeting's primary purpose."
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Oh, that's right. They said there would be. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Abhishek Shrivastava: Machines are coming. Oh my goodness. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Off-topic comment",
                    "definition": "A statement that diverts the conversation away from the main agenda or scientific discussion, potentially hindering progress.",
                    "justification": "The speaker makes a dramatic, off-topic remark, 'Machines are coming. Oh my goodness.', which is a reaction to a bot and not relevant to the scientific problem domain or team formation goals."
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Okay, yeah, so maybe um if if uh we want to sort of maybe start with introductions. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Hesitant Suggestion",
                    "definition": "The speaker proposes an action or idea using tentative or hedging language, which may convey a lack of assertiveness or confidence.",
                    "justification": "The speaker uses multiple softening words such as 'maybe,' 'um,' and 'sort of' when suggesting to begin introductions, as evidenced by 'maybe um if if uh we want to sort of maybe start with introductions.'"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Uh, yeah, I introduced myself in the main room, but um my name is Emily Balskus. I'm a professor of chemistry at Harvard and um yeah, I'm interested in uh gut microbial metabolism and enzymes of also my lab is interested in in um synthesizing and and discovering small molecule inhibitors of gut microbial enzymes. So that's I think one reason why uh I'm a little connected to this this topic. Um yeah, maybe to make things easy, we can just kind of, you know, each call out the next person for intros. Uh, so maybe Sandra. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Unilateral Process Setting",
                    "definition": "The speaker proposes and immediately implements a procedural rule or method for the group without first seeking explicit consensus or input from other participants.",
                    "justification": "Emily suggests a method for introductions and then immediately directs the next speaker, stating, \"maybe to make things easy, we can just kind of, you know, each call out the next person for intros. Uh, so maybe Sandra.\" This action bypasses collaborative decision-making on the group's process."
                }
            ]
        }
    },
    {
        "utterance": "Sandra Laney: Hi everybody. I'm Sandra Laney. I'm the senior program director for Science Innovation at the Walder Foundation. So I don't have any direct connection with any of this and mostly I'm here as an observer and listener, but very interested, um really love the Silog format and uh just FYI the Walder Foundation is based out of the Chicago area. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Disclaiming Direct Involvement/Expertise",
                    "definition": "The speaker explicitly states a lack of direct connection, expertise, or active participation in the scientific topic or potential collaborative effort, positioning themselves primarily as an observer.",
                    "justification": "Sandra explicitly states, \"I don't have any direct connection with any of this and mostly I'm here as an observer and listener,\" which clearly indicates a lack of direct involvement and a passive role, potentially signaling unavailability for collaboration."
                }
            ]
        }
    },
    {
        "utterance": "Sandra Laney: So I'll I'll stop there and just observe. Thank you. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Disengagement from active discussion",
                    "definition": "The speaker explicitly states their intention to cease active participation or contribution to the ongoing scientific discussion, positioning themselves as an observer rather than a collaborator.",
                    "justification": "The speaker explicitly states, \"I'll I'll stop there and just observe,\" indicating a withdrawal from active contribution to the scientific discussion, which can hinder collaborative idea generation and team formation."
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Okay, great. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Stavroula Hatzios: I can go next to just jump in. Uh, my name is Stavroula Hatzios. I'm an assistant professor in uh the molecular cellular and developmental biology department at Yale and Department of Chemistry and then a interdisciplinary microbial Sciences Institute. Um, my lab studies host microbe interactions in the GI tract using both um chemical, biochemical and microbiological approaches. Um and I'll pass it to Harris. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Harris Wang: Right. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Harris Wang: Yeah, uh Harris Wang, I'm I'm a social professor in Systems Biology at the Columbia Medical School. Um, my lab's interested in in uh genomic and genetic engineering technologies for for manipulating microbes and uh, you know, we're we're quite excited about um uh engineering kind of non-canonical organisms, uh, you know, things like uh Clostridia and other species as well as cultivating them. So, um looking forward to the discussion. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Harris Wang: And uh, Emily, sorry, Elizabeth, sorry. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Participant Misidentification",
                    "definition": "The speaker incorrectly addresses another participant by name, which can signal a lack of attention or engagement with the group members.",
                    "justification": "The speaker mistakenly called the next participant 'Emily' before correcting to 'Elizabeth,' as evidenced by the quote 'Emily, sorry, Elizabeth, sorry.'"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Hey, I'm Elizabeth Bess. I'm an assistant professor in chemistry and molecular biology and biochemistry at UC Irvine. And my lab studies uh the the chemistry of the microbiome. So what are the the molecules that are swimming around in the gut and how do they change the activity of microbes in the gut. Um, particularly as it relates to neurobiology, we're interested in understanding mechanisms of alpha aggregation within the context of the gut. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Um. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Tanya. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tanya Nguyen: Hi everyone, I'm Tanya Gwen. I'm an assistant professor of psychiatry at UC San Diego. Um, I'm a clinical and and research neuropsychologist by training and my research broadly aims to identify biomarkers of accelerated aging in mental illness and particularly in schizophrenia. So I'm really interested in microbial and metabolite interactions in schizophrenia and how they contribute to cardio metabolic disturbances, cognitive impairment and inflammation. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tanya Nguyen: Um. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tanya Nguyen: And uh Lawrence. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lawrence David: Uh, I'm Lawrence David. I'm an assistant professor of molecular genetics and microbiology at Duke. Um, I was trained as a biomedical engineer and um a microbial ecologist. Now our lab works a lot at the interface of um diet and nutrition and the gut microbiome and we think about dietary um manipulations to reshape microbial communities. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lawrence David: And then um Tim. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tim Sampson: My name's Tim Sampson. I'm an assistant professor in the Department of Physiology, about to get moved to cell biology uh at Emory University. And my lab is interested in understanding how microbes may trigger neurodegenerative processes, particularly in models of Parkinson's. We're dabbling in Alzheimer's disease. We also are becoming extremely interested in how microbes might uh alter recovery of the enteric nervous system after neurological trauma such as spinal cord injury. And so identifying those particular pathways and mechanisms. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Presenting Disparate Research Interests",
                    "definition": "The speaker describes multiple, distinct research interests or projects without clearly articulating a unifying theme or primary focus, potentially making it difficult for collaborators to identify a specific area for partnership or for a grant proposal to have a clear scope.",
                    "justification": "The speaker outlines two distinct areas: 'how microbes may trigger neurodegenerative processes, particularly in models of Parkinson's. We're dabbling in Alzheimer's disease' and 'how microbes might uh alter recovery of the enteric nervous system after neurological trauma such as spinal cord injury.' While both involve microbes and the nervous system, they represent different disease contexts and research questions, which could suggest a broad or unfocused research agenda for a potential collaboration."
                },
                {
                    "code_name": "Understating Expertise",
                    "definition": "The speaker uses language that explicitly minimizes or downplays their lab's current level of expertise, commitment, or established work in a particular research area.",
                    "justification": "The speaker states, 'We're dabbling in Alzheimer's disease,' which explicitly suggests a casual or less serious engagement with that research area, potentially signaling a lack of deep expertise or commitment to collaborators."
                }
            ]
        }
    },
    {
        "utterance": "Tim Sampson: And uh Abhishek. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Abhishek Shrivastava: Hi, I'm Abhishek Srivastava. I'm an assistant professor at Arizona State University. I'm at the School of Life Sciences and the Biodesign Institute. My lab has two major topics. One is we study the well we try to study the structure of the microbiome and we are focused on the oral microbiome at this point, but we are also dabbling into the gut microbiome a bit. And we try to understand what are the factors that shape the microbiota essentially. And then the other project is on the type nine secretion system, which is a secretion system found in bacteria of the phyla bacteroidetes and we are trying to understand what are the, you know, sensory regulators of that secretion system and how secretion of proteins via that secretion system in and with animal model would lead to physiological changes downstream. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Overly detailed self-introduction",
                    "definition": "The speaker provides an extensive and highly specific description of their research, potentially overwhelming listeners with details or presenting multiple distinct topics without clear overarching connections, making it difficult for others to quickly grasp collaboration opportunities.",
                    "justification": "The speaker's introduction is lengthy and delves into highly specific details of two distinct research areas, including technical jargon, which might make it challenging for listeners to quickly identify core expertise or potential collaboration points. For example, 'My lab has two major topics. One is we study the well we try to study the structure of the microbiome... And then the other project is on the type nine secretion system, which is a secretion system found in bacteria of the phyla bacteroidetes and we are trying to understand what are the, you know, sensory regulators of that secretion system and how secretion of proteins via that secretion system in and with animal model would lead to physiological changes downstream.'"
                }
            ]
        }
    },
    {
        "utterance": "Abhishek Shrivastava: So that's about me and I believe I've I've we've heard from everybody on my screen, but Yang. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Premature assumption",
                    "definition": "The speaker makes an unverified assumption about the current state or progress of the group, which is later shown to be incorrect.",
                    "justification": "The speaker incorrectly assumes that all participants except one have introduced themselves, stating, \"I believe I've I've we've heard from everybody on my screen, but Yang.\" This assumption is premature as another participant introduces themselves afterward."
                }
            ]
        }
    },
    {
        "utterance": "Yang-Yu Liu: Hi everyone. my name is Yang. I'm associate professor of medicine at Woman's Hospital and the Harvard Medical School. I was trained as a statistical physicist. So I'm study complex um the micro as a complex ecosystem and right now I'm focusing on how to design a probiotic cocktail to decolonize certain pathogens and I I'll be happy to apply this approach to uh uh more complex diseases. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Yang-Yu Liu: Thank you. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Okay. And um I think I'm the last one. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Maayan Levy: Yeah, yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Maayan Levy: Okay. Um, I'm not sure if it's because no one was able to pronounce my name. So uh, my name is Mayan Levy. I'm I'm from the University of Pennsylvania. Um, I've opened my lab uh three years ago. I'm originally from Israel. Um, and my lab is focused on on understanding the communication between the host and the microbiome, specifically in the gut and we focus on mainly on epithelial cells. Um, and what we're trying to do is to identify how the microbiome communicates with the cells of the host, mainly through microbial metabolites and and understanding this black box of metabolites that is present in the gut. And on the other hand, from the side of the host, we're trying to identify new receptors or new sensors for these metabolites and and using um different mouse models of um intestinal diseases, we and and um different knockout mice, we we try to identify the function of these receptors and what are the the consequences of of um changing their expression um and in terms of different diseases such as uh cancer, um IBD and and more. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Excessive detail in introduction",
                    "definition": "Providing an extensive and highly technical description of one's research during an initial introductory round, which can overwhelm listeners and make it difficult to quickly identify common interests or collaboration points.",
                    "justification": "The speaker delivers a very long and detailed monologue about their lab's specific research focus, methodologies, and disease models, using numerous technical terms, which is disproportionate for an initial self-introduction in a multi-speaker setting. For example, \"Um, and my lab is focused on on understanding the communication between the host and the microbiome, specifically in the gut and we focus on mainly on epithelial cells. Um, and what we're trying to do is to identify how the microbiome communicates with the cells of the host, mainly through microbial metabolites and and understanding this black box of metabolites that is present in the gut. And on the other hand, from the side of the host, we're trying to identify new receptors or new sensors for these metabolites and and using um different mouse models of um intestinal diseases, we and and um different knockout mice, we we try to identify the function of these receptors and what are the the consequences of of um changing their expression um and in terms of different diseases such as uh cancer, um IBD and and more.\""
                }
            ]
        }
    },
    {
        "utterance": "Maayan Levy: Thank you. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Great, thanks. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Yeah, so this is a huge diversity of different interests and expertise, which is awesome. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Um, yeah, so maybe we can just start by uh sort of going around and and and sharing the questions or ideas that you have for discussion topics. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: So anybody who wants to can can go ahead and start. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Maayan Levy, UPenn: decision to be uh more um conserved or more um maybe a bit more similar between different individuals. Um so the um metabolomics between different individuals is more similar uh compared to or if we look at at the composition between different individuals. Yeah, just a thought. I I don't know how to do it. Um but yeah, the this complexity is is is something that that we need to address. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Downplaying Contribution",
                    "definition": "The speaker minimizes the significance or value of their own idea or contribution, which can discourage further discussion or development of the idea.",
                    "justification": "The speaker explicitly reduces the importance of their preceding scientific observation by stating, \"Yeah, just a thought.\""
                },
                {
                    "code_name": "Expressing Inability to Solve",
                    "definition": "The speaker explicitly states their personal inability to find a solution or a method to address the problem they have raised, potentially stalling collaborative problem-solving.",
                    "justification": "The speaker directly admits a lack of a concrete approach or solution by saying, \"I I don't know how to do it.\""
                }
            ]
        }
    },
    {
        "utterance": "Lawrence David: Those are all fantastic things to record. I feel like you just enumerated half of our first slide. I'm curious, um, because we, um, have seen with different kinds of like dietary manipulations that certainly there is like some still variation even in in the the response or the activity. Do people know what the exact activity even we want to modulate for, um, benefiting, um, you know, neurobiology? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Demanding premature specificity",
                    "definition": "Requiring a level of detail or a concrete answer that is not appropriate for the current exploratory stage of discussion, potentially stifling broader ideation.",
                    "justification": "Lawrence David asks for 'the exact activity' the group wants to modulate, which may be too specific for an initial brainstorming session, potentially limiting the exploration of diverse ideas. Quote: \"Do people know what the exact activity even we want to modulate for, um, benefiting, um, you know, neurobiology?\""
                },
                {
                    "code_name": "Expressing skepticism/doubt",
                    "definition": "Communicating a lack of belief or trust in the current ideas or the group's understanding, potentially undermining confidence or discouraging further contribution.",
                    "justification": "The use of 'even' in the question implies doubt about whether the group has a clear understanding of the 'exact activity' they want to modulate. Quote: \"Do people know what the exact activity *even* we want to modulate for...\""
                }
            ]
        }
    },
    {
        "utterance": "Tim Sampson (he/him)- Emory University: I think that's that's such a broad broad point because we don't necessarily know that, I think. I I don't think there's one thing we can point to that's that's universal for a neurological outcome. But there's definitely examples of specific things. So like ketogenic diet for epilepsy for instance is shown to modulate uh glutamate and glutamine ratios in the brain. And so that's one very specific thing. But I don't think we can generally make some argument that modulating the microbiome in a certain way will always have a neurological effect. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Dismisses/Downplays Idea",
                    "definition": "The speaker minimizes the importance or validity of a previously stated idea or question, often by labeling it as too general or unknowable, which can discourage further discussion.",
                    "justification": "The speaker dismisses the previous point as 'that's such a broad broad point because we don't necessarily know that,' implying it's too vague or unanswerable to be productive."
                },
                {
                    "code_name": "Expresses Skepticism/Doubt",
                    "definition": "The speaker voices significant doubt or disbelief regarding the general applicability, universality, or effectiveness of a concept or approach being discussed.",
                    "justification": "The speaker expresses strong doubt about a general hypothesis by stating, 'But I don't think we can generally make some argument that modulating the microbiome in a certain way will always have a neurological effect.'"
                }
            ]
        }
    },
    {
        "utterance": "Abhishek Shrivastava, ASU: I mean, I'm a bit curious about the term modulation over here. Like if you think about electronics and telecommunication and you know, things like that, you have a periodic waveform and then you, you know, try to change the, you know, amplitude of it or, you know, the frequency of that in a time in a temporal fashion. Okay. So are we, you know, going to follow a line of thought where we think that the signals that are generated by the microbes that are present in the gut vary as a function of time and do we then want to change those signals as a function of time and do we think there is a, you know, cyclic repetition of those of the production of those signals? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Imposing a specific disciplinary lens",
                    "definition": "The speaker frames a concept or discussion exclusively through the perspective and specialized terminology of their own discipline, potentially limiting broader understanding or alternative viewpoints in a multidisciplinary setting.",
                    "justification": "The speaker introduces a definition of 'modulation' from 'electronics and telecommunication' and then asks if the group should 'follow a line of thought' based on this specific, non-biological interpretation, as seen in 'Like if you think about electronics and telecommunication and you know, things like that, you have a periodic waveform and then you, you know, try to change the, you know, amplitude of it or, you know, the frequency of that in a time in a temporal fashion. Okay. So are we, you know, going to follow a line of thought where we think that the signals that are generated by the microbes that are present in the gut vary as a function of time and do we then want to change those signals as a function of time and do we think there is a, you know, cyclic repetition of those of the production of those signals?'."
                },
                {
                    "code_name": "Focusing on definitional minutiae",
                    "definition": "The speaker dedicates significant discussion time to the precise definition or interpretation of a term, potentially at the expense of advancing broader conceptual or problem-solving discussions.",
                    "justification": "The speaker initiates a detailed inquiry into the exact meaning of 'modulation' and elaborates on its technical interpretation from another field, rather than building on the broader discussion, as evidenced by 'I mean, I'm a bit curious about the term modulation over here. Like if you think about electronics and telecommunication...'."
                }
            ]
        }
    },
    {
        "utterance": "Harris Wang - Columbia University: Yeah, I may may I think, you know, to that point, I think there's the there's a potentially difference between, you know, modulating the composition or the function, right? I think, you know, if we if we define what are the functions, you know, functional modules that are interesting or targets for for perturbation, um, I think that's going to be really key to to all of this because then you can define the the genetic material which you can then for example, drop into a microbe or uh identify microbiota that, you know, exists in in in in a natural community as a source for probiotic supplementation, right? Um I I do think there's a whole component of spatial temporal variation and and how we think about delivery that's important. So, um, you know, for example, a lot of the the analysis are are done on like fecal samples, right? If you if you actually want to get it into the small intestine, like that's going to be, you know, potentially much more challenging where you you you need to require complete different tools. So, um, I think both like very, you know, how do you control that in space as well as in time, um, and there probably just different ways to think about that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Diverges from immediate topic",
                    "definition": "The speaker shifts the discussion away from the specific question or point just raised by another participant, potentially losing focus or failing to directly address the immediate concern.",
                    "justification": "In response to a question about 'signals' and 'cyclic repetition' of microbial output, the speaker shifts the focus by stating, 'I think there's the there's a potentially difference between, you know, modulating the composition or the function, right?' and then discusses genetic material and delivery challenges, rather than directly engaging with the 'signals' aspect."
                },
                {
                    "code_name": "Highlights challenges without solutions",
                    "definition": "The speaker emphasizes difficulties or obstacles related to an idea or approach without simultaneously proposing potential solutions, strategies, or pathways to overcome them.",
                    "justification": "The speaker notes a significant challenge in delivery, stating, 'If you if you actually want to get it into the small intestine, like that's going to be, you know, potentially much more challenging where you you you need to require complete different tools.' This highlights a difficulty without offering a path forward."
                },
                {
                    "code_name": "Overly verbose/dense explanation",
                    "definition": "The speaker provides an explanation that is excessively long, detailed, or introduces too many new concepts, potentially making it difficult for others to follow or engage efficiently.",
                    "justification": "The utterance is very long and packed with multiple distinct ideas, exemplified by the segment: 'if we define what are the functions, you know, functional modules that are interesting or targets for for perturbation, um, I think that's going to be really key to to all of this because then you can define the the genetic material which you can then for example, drop into a microbe or uh identify microbiota that, you know, exists in in in in a natural community as a source for probiotic supplementation, right?' This introduces several complex concepts in a single turn."
                }
            ]
        }
    },
    {
        "utterance": "Abhishek Shrivastava, ASU: And as you mentioned, like what is the definition of it, right? Is that the like is that the physiology of the host or is that the signal produced by the microbiome or microbial diversity? What are what do we want to think about at this point? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Maayan Levy, UPenn: I think that the the interesting point is to to try and modulate the the the activity of the microbiome by, you know, um or not so first of all to to identify how the microbiome or specific molecules that are produced by the microbiome are modulating host response or immune response or any other disease any specific disease. Um and then try to supplement with this specific molecule rather than trying to change microbial composition because this is this is challenging. Um yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Prematurely narrowing scope",
                    "definition": "The speaker dismisses a potential research direction or approach without sufficient exploration or discussion, potentially limiting the breadth of collaborative ideation.",
                    "justification": "The speaker explicitly states a preference for one approach over another, citing 'challenging' as the reason, which might prematurely close off a discussion point: 'Um and then try to supplement with this specific molecule rather than trying to change microbial composition because this is this is challenging.'"
                },
                {
                    "code_name": "Lack of conciseness",
                    "definition": "The speaker's communication is verbose, includes filler words, or takes a long time to convey a relatively simple point, potentially making it difficult for others to follow or engage.",
                    "justification": "The utterance is quite long and contains several filler words ('you know', 'um', 'yeah'), which can make the communication less direct and harder to follow: 'I think that the the interesting point is to to try and modulate the the the activity of the microbiome by, you know, um or not so first of all to to identify how the microbiome or specific molecules that are produced by the microbiome are modulating host response or immune response or any other disease any specific disease. Um and then try to supplement with this specific molecule rather than trying to change microbial composition because this is this is challenging. Um yeah.'"
                }
            ]
        }
    },
    {
        "utterance": "Stavroula Hatzios - Yale: I think another thing to following up on that is to consider the timeline of an intervention that would modulate the microbiome, for example, supplementing with metabolites and and um what's the permanence of that versus so for example, like I think a lot of early probiotic data at least suggests that, you know, even like the the bacteria in yogurt, for example, that will only transiently colonize your gut for a couple days and then pass through. So if you're thinking about effective strategies for modulating the microbiome, what kind of time scale are we talking about? Um this is more of a long-term question and like if you were thinking of a clinical intervention or something, but would this be come in the form of a supplement that you would have to administer like multiple ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    }
]